Publication | Closed Access
A Phase 2 Study of Tofacitinib, an Oral Janus Kinase Inhibitor, in Patients With Crohn’s Disease
295
Citations
16
References
2014
Year
InflammationChronic Inflammatory DiseasesAnti-inflammatoryCrohn ’Gastrointestinal PharmacologyMedicineImmunologyGastroenterologyPhase 2PharmacologyInflammatory DiseaseDigestive System Diseases
| Year | Citations | |
|---|---|---|
Page 1
Page 1